Sendagire H, Kiwuwa S, Dhamani A, Akugizibwe R, Lwasa Y, Bukenya A
Afr Health Sci. 2023; 23(1):1-15.
PMID: 37545952
PMC: 10398495.
DOI: 10.4314/ahs.v23i1.2.
Bhullar K, Nael M, Elokely K, Drews S, Wu J
Pharmaceutics. 2022; 14(10).
PMID: 36297481
PMC: 9607082.
DOI: 10.3390/pharmaceutics14102045.
Churiso G, Diriba K, Girma H, Tafere S
Infect Drug Resist. 2022; 15:4307-4320.
PMID: 35965852
PMC: 9373995.
DOI: 10.2147/IDR.S370907.
da Silva S, do Nascimento J, Mendes R, Guarines K, Targino Alves da Silva C, Silva P
ACS Infect Dis. 2022; 8(9):1758-1814.
PMID: 35940589
PMC: 9380879.
DOI: 10.1021/acsinfecdis.2c00204.
Parvez M, Saha M, Ibrahim M, Araf Y, Islam M, Ohtsuki G
Immun Inflamm Dis. 2022; 10(7):e639.
PMID: 35759231
PMC: 9210926.
DOI: 10.1002/iid3.639.
The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19.
Saghafi N, Rezaee S, Momtazi-Borojeni A, Tavasolian F, Sathyapalan T, Abdollahi E
Life Sci. 2022; 294:120392.
PMID: 35149115
PMC: 8824166.
DOI: 10.1016/j.lfs.2022.120392.
The Plebeian Algorithm: A Democratic Approach to Censorship and Moderation.
Fedoruk B, Nelson H, Frost R, Fucile Ladouceur K
JMIR Form Res. 2021; 5(12):e32427.
PMID: 34854812
PMC: 8691413.
DOI: 10.2196/32427.
How Viruses Use the VCP/p97 ATPase Molecular Machine.
Das P, Dudley J
Viruses. 2021; 13(9).
PMID: 34578461
PMC: 8473244.
DOI: 10.3390/v13091881.
Effectiveness of Pulmonary Rehabilitation in Severe and Critically Ill COVID-19 Patients: A Controlled Study.
Busching G, Zhang Z, Schmid J, Sigrist T, Khatami R
Int J Environ Res Public Health. 2021; 18(17).
PMID: 34501549
PMC: 8430691.
DOI: 10.3390/ijerph18178956.
COVID-19 vulnerabilities are intensified by declining human serum albumin levels.
Johnson A, Winlow W
Exp Physiol. 2021; 107(7):674-682.
PMID: 34275164
PMC: 8447469.
DOI: 10.1113/EP089703.
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19.
Sharma A, Kontodimas K, Bosmann M
Front Med (Lausanne). 2021; 8:648005.
PMID: 34150793
PMC: 8211875.
DOI: 10.3389/fmed.2021.648005.
Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.
Buchan B, Yao J
Clin Microbiol Newsl. 2021; 43(11):89-96.
PMID: 34035555
PMC: 8138692.
DOI: 10.1016/j.clinmicnews.2021.05.004.
